Literature DB >> 33693750

Gag p24 Is a Marker of Human Immunodeficiency Virus Expression in Tissues and Correlates With Immune Response.

Guoxin Wu1, Paul Zuck1, Shih Lin Goh1, Jeffrey M Milush2, Poonam Vohra3, Joseph K Wong4, Ma Somsouk5, Steven A Yukl4, Barbara L Shacklett6, Nicolas Chomont7, Ashley T Haase8, Hiroyu Hatano9, Timothy W Schacker10, Steven G Deeks9, Daria J Hazuda1, Peter W Hunt2, Bonnie J Howell1.   

Abstract

We demonstrate that human immunodeficiency virus (HIV) gag p24 protein is more readily detected in gut and lymph node tissues than in blood CD4+ T cells and correlates better with CD4 count during antiretroviral therapy (ART). Gut p24 levels also measurably decline with ART in natural controllers. During ART, gut p24 expression is more strongly associated both with HIV-specific CD8+ T-cell frequency and plasma soluble CD14 levels than gut HIV RNA expression. This study supports using gag p24 as a marker of HIV expression in HIV+ tissues to study effects of viral persistence and to monitor efficacy of treatment in HIV-based clearance studies.
© The Author(s) 2021. Published by Oxford University Press for the Infectious Diseases Society of America. All rights reserved. For permissions, e-mail: journals.permissions@oup.com.

Entities:  

Keywords:  HIV; HIV persistence; biomarker; fine needle aspirates; gag p24; lymph nodes; rectal biopsy

Mesh:

Substances:

Year:  2021        PMID: 33693750      PMCID: PMC8599810          DOI: 10.1093/infdis/jiab121

Source DB:  PubMed          Journal:  J Infect Dis        ISSN: 0022-1899            Impact factor:   5.226


  15 in total

1.  Persistent HIV-1 replication is associated with lower antiretroviral drug concentrations in lymphatic tissues.

Authors:  Courtney V Fletcher; Kathryn Staskus; Stephen W Wietgrefe; Meghan Rothenberger; Cavan Reilly; Jeffrey G Chipman; Greg J Beilman; Alexander Khoruts; Ann Thorkelson; Thomas E Schmidt; Jodi Anderson; Katherine Perkey; Mario Stevenson; Alan S Perelson; Daniel C Douek; Ashley T Haase; Timothy W Schacker
Journal:  Proc Natl Acad Sci U S A       Date:  2014-01-27       Impact factor: 11.205

2.  HDAC inhibition induces HIV-1 protein and enables immune-based clearance following latency reversal.

Authors:  Guoxin Wu; Michael Swanson; Aarthi Talla; Donald Graham; Julie Strizki; Daniel Gorman; Richard Jo Barnard; Wade Blair; Ole S Søgaard; Martin Tolstrup; Lars Østergaard; Thomas A Rasmussen; Rafick-Pierre Sekaly; Nancie M Archin; David M Margolis; Daria J Hazuda; Bonnie J Howell
Journal:  JCI Insight       Date:  2017-08-17

Review 3.  Immunological approaches to HIV cure.

Authors:  Adam R Ward; Talia M Mota; R Brad Jones
Journal:  Semin Immunol       Date:  2020-09-24       Impact factor: 11.130

Review 4.  Immunologic Biomarkers, Morbidity, and Mortality in Treated HIV Infection.

Authors:  Peter W Hunt; Sulggi A Lee; Mark J Siedner
Journal:  J Infect Dis       Date:  2016-10-01       Impact factor: 5.226

5.  Cell-based measures of viral persistence are associated with immune activation and programmed cell death protein 1 (PD-1)-expressing CD4+ T cells.

Authors:  Hiroyu Hatano; Vivek Jain; Peter W Hunt; Tzong-Hae Lee; Elizabeth Sinclair; Tri D Do; Rebecca Hoh; Jeffrey N Martin; Joseph M McCune; Frederick Hecht; Michael P Busch; Steven G Deeks
Journal:  J Infect Dis       Date:  2012-10-22       Impact factor: 5.226

Review 6.  HIV persistence in subsets of CD4+ T cells: 50 shades of reservoirs.

Authors:  Rémi Fromentin; Nicolas Chomont
Journal:  Semin Immunol       Date:  2020-11-30       Impact factor: 11.130

7.  HIV-Specific T Cell Responses Are Highly Stable on Antiretroviral Therapy.

Authors:  Yinyan Xu; Ilana M Trumble; Joanna A Warren; Genevieve Clutton; Maria Abad-Fernandez; Jennifer Kirchnerr; Adaora A Adimora; Steven G Deeks; David M Margolis; JoAnn D Kuruc; Cynthia L Gay; Nancie M Archin; Katie R Mollan; Michael Hudgens; Nilu Goonetilleke
Journal:  Mol Ther Methods Clin Dev       Date:  2019-08-14       Impact factor: 6.698

8.  Defective HIV-1 proviruses produce viral proteins.

Authors:  Hiromi Imamichi; Mindy Smith; Joseph W Adelsberger; Taisuke Izumi; Francesca Scrimieri; Brad T Sherman; Catherine A Rehm; Tomozumi Imamichi; Alice Pau; Marta Catalfamo; Anthony S Fauci; H Clifford Lane
Journal:  Proc Natl Acad Sci U S A       Date:  2020-02-06       Impact factor: 11.205

9.  Prospective antiretroviral treatment of asymptomatic, HIV-1 infected controllers.

Authors:  Hiroyu Hatano; Steven A Yukl; April L Ferre; Erin H Graf; Ma Somsouk; Elizabeth Sinclair; Mohamed Abdel-Mohsen; Teri Liegler; Kara Harvill; Rebecca Hoh; Sarah Palmer; Peter Bacchetti; Peter W Hunt; Jeffrey N Martin; Joseph M McCune; Russell P Tracy; Michael P Busch; Una O'Doherty; Barbara L Shacklett; Joseph K Wong; Steven G Deeks
Journal:  PLoS Pathog       Date:  2013-10-10       Impact factor: 6.823

10.  A quantitative approach for measuring the reservoir of latent HIV-1 proviruses.

Authors:  Katherine M Bruner; Zheng Wang; Francesco R Simonetti; Alexandra M Bender; Kyungyoon J Kwon; Srona Sengupta; Emily J Fray; Subul A Beg; Annukka A R Antar; Katharine M Jenike; Lynn N Bertagnolli; Adam A Capoferri; Joshua T Kufera; Andrew Timmons; Christopher Nobles; John Gregg; Nikolas Wada; Ya-Chi Ho; Hao Zhang; Joseph B Margolick; Joel N Blankson; Steven G Deeks; Frederic D Bushman; Janet D Siliciano; Gregory M Laird; Robert F Siliciano
Journal:  Nature       Date:  2019-01-30       Impact factor: 49.962

View more
  4 in total

Review 1.  Research priorities for an HIV cure: International AIDS Society Global Scientific Strategy 2021.

Authors:  Steven G Deeks; Nancie Archin; Paula Cannon; Simon Collins; R Brad Jones; Marein A W P de Jong; Olivier Lambotte; Rosanne Lamplough; Thumbi Ndung'u; Jeremy Sugarman; Caroline T Tiemessen; Linos Vandekerckhove; Sharon R Lewin
Journal:  Nat Med       Date:  2021-12-01       Impact factor: 53.440

2.  No evidence that circulating HIV-specific immune responses contribute to persistent inflammation and immune activation in persons on long-term ART.

Authors:  Adam R Ward; Allison S Thomas; Eva M Stevenson; Szu-Han Huang; Sheila M Keating; Rajesh T Gandhi; Deborah K McMahon; Ronald J Bosch; Bernard J Macatangay; Joshua C Cyktor; Joseph J Eron; John W Mellors; R Brad Jones
Journal:  AIDS       Date:  2022-06-22       Impact factor: 4.632

Review 3.  Long-term immunologic effects of SARS-CoV-2 infection: leveraging translational research methodology to address emerging questions.

Authors:  Michael J Peluso; Joanna Donatelli; Timothy J Henrich
Journal:  Transl Res       Date:  2021-11-12       Impact factor: 7.012

4.  Combination strategies to durably suppress HIV-1: Soluble T cell receptors.

Authors:  Zoë Wallace; Praveen K Singh; Lucy Dorrell
Journal:  J Virus Erad       Date:  2022-08-24
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.